|
Pulmonary circulation and disease
Citations 261-270 of 387 total displayed.
|
Past content
(since Feb 1999):
|
- Basic Science Reports
Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension
- Benoît Rondelet, François Kerbaul, Sophie Motte, Ronald van Beneden, Myriam Remmelink, Serge Brimioulle, Kathleen McEntee, Pierre Wauthy, Isabelle Salmon, Jean-Marie Ketelslegers, and Robert Naeije
Circulation 2003;107:1329-1335; published online before print as doi:10.1161/01.CIR.0000053443.27512.33
[Abstract]
[Full text]
- Basic Science Reports
Metabolism of Asymmetric Dimethylarginines Is Regulated in the Lung Developmentally and With Pulmonary Hypertension Induced by Hypobaric Hypoxia
- Francesca I. Arrigoni, Patrick Vallance, Sheila G. Haworth, and James M. Leiper
Circulation 2003;107:1195-1201; published online before print as doi:10.1161/01.CIR.0000051466.00227.13
[Abstract]
[Full text]
- Articles
Influence of Inhaled Iloprost on Transpulmonary Gradient of Big Endothelin in Patients With Pulmonary Hypertension
- H. Wilkens, M. Bauer, N. Forestier, J. König, A. Eichler, S. Schneider, H. J. Schäfers, and G. W. Sybrecht
Circulation published February 24, 2003, doi:10.1161/01.CIR.0000056104.49686.4B
[Abstract]
- Articles
Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension
- Benoît Rondelet, François Kerbaul, Sophie Motte, Ronald van Beneden, Myriam Remmelink, Serge Brimioulle, Kathleen McEntee, Pierre Wauthy, Isabelle Salmon, Jean-Marie Ketelslegers, and Robert Naeije
Circulation published February 17, 2003, doi:10.1161/01.CIR.0000053443.27512.33
[Abstract]
- Articles
Metabolism of Asymmetric Dimethylarginines Is Regulated in the Lung Developmentally and With Pulmonary Hypertension Induced by Hypobaric Hypoxia
- Francesca I. Arrigoni, Patrick Vallance, Sheila G. Haworth, and James M. Leiper
Circulation published February 17, 2003, doi:10.1161/01.CIR.0000051466.00227.13
[Abstract]
- Brief Rapid Communications
Beneficial Effects of Phosphodiesterase 5 Inhibition in Pulmonary Hypertension Are Influenced by Natriuretic Peptide Activity
- Lan Zhao, Nicola A. Mason, Julian W. Strange, Hamish Walker, and Martin R. Wilkins
Circulation 2003;107:234-237; published online before print as doi:10.1161/01.CIR.0000050653.10758.6B
[Abstract]
[Full text]
- Brief Rapid Communications
Beneficial Effects of Phosphodiesterase 5 Inhibition in Pulmonary Hypertension Are Influenced by Natriuretic Peptide Activity
- Lan Zhao, Nicola A. Mason, Julian W. Strange, Hamish Walker, and Martin R. Wilkins
Circulation published December 30, 2002, doi:10.1161/01.CIR.0000050653.10758.6B
[Abstract]
- Cardiology Patient Pages
Pulmonary Hypertension
- Jacques I. Benisty
Circulation 2002;106:e192-194e, doi:10.1161/01.CIR.0000042762.47822.FE
[Full text]
- Clinical Investigations and Reports
Analysis of Cardiovascular Phenotype and Genotype-Phenotype Correlation in Individuals With a JAG1 Mutation and/or Alagille Syndrome
- Doff B. McElhinney, Ian D. Krantz, Lynn Bason, David A. Piccoli, Karan M. Emerick, Nancy B. Spinner, and Elizabeth Goldmuntz
Circulation 2002;106:2567-2574; published online before print as doi:10.1161/01.CIR.0000037221.45902.69
[Abstract]
[Full text]
- Clinical Investigations and Reports
Scores for Post–Myocardial Infarction Risk Stratification in the Community
- Mandeep Singh, Guy S. Reeder, Steven J. Jacobsen, Susan Weston, Jill Killian, and Véronique L. Roger
Circulation 2002;106:2309-2314; published online before print as doi:10.1161/01.CIR.0000036598.12888.DE
[Abstract]
[Full text]
|
|
